NFE2L2 and cancer: The catalytic activity of the FN3K deglycating enzyme has a significant role in cancer cells to modulate the oncogenic activity of Nrf2, as the blockade of FN3K could induce glycated Nrf2 to remain Nrf2 in an inactive state (Figure 3B) [87].